Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer
PHASE2
This is a Phase 2, open-label, multicenter study to assess the efficacy and...
Status
Completed
Location
UCSF Helen Diller Medical Center at Parnassus Heights